GlaxoSmithKline (GSK) Backs Thrasos Therapeutics With $35 Million for Acute Kidney Injury Tx Research
10/25/2012 7:12:09 AM
More...
|
Thrasos Therapeutics and Collaborators Publish Nature Medicine Research Article Detailing Potential Treatment Approach for Kidney Disease
2/7/2012 6:54:02 AM
More...
|
Thrasos Therapeutics Appoints Dr. Andreas Orfanos as Chief Medical Officer
9/20/2011 10:10:52 AM
More...
|
Thrasos Therapeutics Initiates Phase 1 Clinical Trial for THR-184 in Acute Kidney Injury
9/13/2011 10:25:43 AM
More...
|
Thrasos Therapeutics Issued U.S. Patent for First-in-Class Compounds That Selectively Target Key Receptors of the Bone Morphogenetic Protein Pathway
3/3/2009 9:24:05 AM
More...
|
Biotech Veteran Wilcox To Become CEO Of Drug Discovery Company, Thrasos Inc.
4/17/2006 10:49:09 AM
More...
|